Ragini Vuppugalla

1.3k total citations
27 papers, 898 citations indexed

About

Ragini Vuppugalla is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Ragini Vuppugalla has authored 27 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Ragini Vuppugalla's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Ragini Vuppugalla is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Ragini Vuppugalla collaborates with scholars based in United States, Switzerland and Belgium. Ragini Vuppugalla's co-authors include Reza Mehvar, Christopher R. Gibson, M. Sherry Ku, Vikash K. Sinha, Kimberly K. Adkison, Thierry Lavé, Volker Fischer, Rhys D.O. Jones, Barbara J. Ring and Thorir D. Bjornsson and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Ragini Vuppugalla

27 papers receiving 850 citations

Peers

Countries citing papers authored by Ragini Vuppugalla

Since Specialization

Citations

This map shows the geographic impact of Ragini Vuppugalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragini Vuppugalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragini Vuppugalla more than expected).

Fields of papers citing papers by Ragini Vuppugalla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ragini Vuppugalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragini Vuppugalla. The network helps show where Ragini Vuppugalla may publish in the future.

Co-authorship network of co-authors of Ragini Vuppugalla

This figure shows the co-authorship network connecting the top 25 collaborators of Ragini Vuppugalla. A scholar is included among the top collaborators of Ragini Vuppugalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ragini Vuppugalla. Ragini Vuppugalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate 2021 ·ACS Medicinal Chemistry Letters ·Robert J. Cherney, (unknown), (unknown), Douglas G. Batt, (unknown), Anne Rose, Ragini Vuppugalla, Jing Chen, Jian Pang, (unknown), Melissa Yarde, Andrew J. Tebben, (unknown), Mary Ellen Cvijic, Arvind Mathur, Joel C. Barrish, Sandhya Mandlekar, Qihong Zhao, Percy H. Carter	33
2	Abstract 3760: Preclinical antitumor activity of a CC chemokine receptor (CCR) 2/5 dual antagonist as monotherapy and in combination with immune checkpoint blockade 2018 ·Cancer Research ·Qihong Zhao, Anwar Murtaza, (unknown), (unknown), (unknown), Ragini Vuppugalla, Robert J. Cherney, Kevin Stefanski, Z. Alexander Cao, Ashwin R. Sama, Arvin Yang, Mary Struthers, Miguel A. F. Sanjuán, John T. Hunt, Percy Carter, Luisa Salter–Cid	8
3	Comparison of physiologic and pharmacologic parameters in Asian and mauritius cynomolgus macaques 2015 ·Regulatory Toxicology and Pharmacology ·(unknown), Jagannatha V. Mysore, (unknown), Hermann Burr, Jinze Li, Nelly Aranı́bar, Ragini Vuppugalla, (unknown), Raja S. Mangipudy, Michael J. Graziano	21
4	Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport 2015 ·Experimental Cell Research ·Randy Talbott, R. M. Borzilleri, Charu Chaudhry, Joseph Fargnoli, Henry Shen, Craig Fairchild, Bryan C. Barnhart, (unknown), Thomas McDonagh, Ragini Vuppugalla, Gregory D. Vite, John T. Hunt, Marco M. Gottardis, Joseph G. Naglich	3
5	Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19 2012 ·Drug Metabolism and Disposition ·Tatyana Zvyaga, Shu‐Ying Chang, Cliff Chen, Zheng Yang, Ragini Vuppugalla, (unknown), (unknown), Andrew J. Wagner, Anjaneya Chimalakonda, A. David Rodrigues	99
6	Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats 2012 ·Xenobiotica ·Ragini Vuppugalla, Yueping Zhang, Shu Chang, A. David Rodrigues, Punit H. Marathe	10
7	PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution 2011 ·Journal of Pharmaceutical Sciences ·Rhys D.O. Jones, Hannah M. Jones, Malcolm Rowland, Christopher R. Gibson, James Yates, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, M. Sherry Ku, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir D. Bjornsson, Thierry Lavé, Patrick Poulin	104
8	PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach 2011 ·Journal of Pharmaceutical Sciences ·Patrick Poulin, Rhys D.O. Jones, Hannah M. Jones, Christopher R. Gibson, Malcolm Rowland, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, M. Sherry Ku, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir D. Bjornsson, Thierry Lavé, James Yates	132
9	PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach 2011 ·Journal of Pharmaceutical Sciences ·Ragini Vuppugalla, Punit Marathe, Handan He, Rhys D.O. Jones, James Yates, Hannah M. Jones, Christopher R. Gibson, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, M. Sherry Ku, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir D. Bjornsson, Thierry Lavé, Patrick Poulin	49
10	PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance 2011 ·Journal of Pharmaceutical Sciences ·Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison, Hannah M. Jones, Malcolm Rowland, Rhys D.O. Jones, James Yates, M. Sherry Ku, Christopher R. Gibson, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir D. Bjornsson, Thierry Lavé, Patrick Poulin	148
11	Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2 2010 ·Blood ·Ashok V. Purandare, Animesh Pardanani, (unknown), Marco M. Gottardis, Terra L. Lasho, Dan You, Louis J. Lombardo, Becky Penhallow, Ragini Vuppugalla, George L. Trainor, Ayalew Tefferi, Matthew V. Lorenzi	4
12	Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction 2009 ·Drug Metabolism and Disposition ·Sean Kim, Joseph Dinchuk, (unknown), (unknown), Mary Zoeckler, (unknown), Kathleen Mosure, Ragini Vuppugalla, James E. Grace, (unknown), (unknown), Jennifer Pizzano, Michael Sinz	39
13	Effect of Commonly Used Organic Solvents on the Kinetics of Cytochrome P450 2B6- and 2C8-Dependent Activity in Human Liver Microsomes 2007 ·Drug Metabolism and Disposition ·Ragini Vuppugalla, Shu‐Ying Chang, Hongjian Zhang, Punit H. Marathe, (unknown)	27
14	Hepatic Disposition of the Cytochrome P450 2E1 Marker Chlorzoxazone and its Hydroxylated Metabolite in Isolated Perfused Rat Livers 2006 ·Journal of Pharmaceutical Sciences ·Reza Mehvar, Ragini Vuppugalla	15
15	Route‐dependent stereoselective pharmacokinetics of tramadol and its activeO‐demethylated metabolite in rats 2006 ·Chirality ·(unknown), Ragini Vuppugalla, Katherine J. Elliott, Reza Mehvar	26
16	SELECTIVE EFFECTS OF NITRIC OXIDE ON THE DISPOSITION OF CHLORZOXAZONE AND DEXTROMETHORPHAN IN ISOLATED PERFUSED RAT LIVERS 2006 ·Drug Metabolism and Disposition ·Ragini Vuppugalla, Reza Mehvar	6
17	ENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450 2005 ·Drug Metabolism and Disposition ·Ragini Vuppugalla, Reza Mehvar	9
18	SHORT-TERM INHIBITORY EFFECTS OF NITRIC OXIDE ON CYTOCHROME P450-MEDIATED DRUG METABOLISM: TIME DEPENDENCY AND REVERSIBILITY PROFILES IN ISOLATED PERFUSED RAT LIVERS 2004 ·Drug Metabolism and Disposition ·Ragini Vuppugalla, Reza Mehvar	22
19	Hepatic Disposition and Effects of Nitric Oxide Donors: Rapid and Concentration-Dependent Reduction in the Cytochrome P450-Mediated Drug Metabolism in Isolated Perfused Rat Livers 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Ragini Vuppugalla, Reza Mehvar	25
20	Microsomal Cytochrome P450 Levels and Activities of Isolated Rat Livers Perfused with Albumin 2003 ·Pharmaceutical Research ·Ragini Vuppugalla, Rakhi B. Shah, Anjaneya Chimalakonda, Charles Fisher, Reza Mehvar	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact